Tenax Therapeutics, Inc.
General ticker "TENX" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $215.9M (TTM average)
Tenax Therapeutics, Inc. follows the US Stock Market performance with the rate: 38.0%.
Estimated limits based on current volatility of 3.6%: low 8.86$, high 9.52$
Factors to consider:
- Total employees count: 6 (-25.0%) as of 2023
- Top business risk factors: Inability to continue as a going concern, Economic downturns and volatility, Fluctuating operating results, Product development delays, Market acceptance
- Price in estimated range
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [3.02$, 9.87$]
- 2025-12-31 to 2026-12-31 estimated range: [1.47$, 5.16$]
Financial Metrics affecting the TENX estimates:
- Positive: with PPE of -1.1 at the end of fiscal year the price was low
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -16.59 <= 0.33
- Negative: negative Industry operating cash flow (median)
- Negative: negative Net income
- Positive: Industry inventory ratio change (median), % of 0 <= 0
- Positive: Investing cash flow per share per price, % of 0 > -0.66
- Positive: Shareholder equity ratio, % of 95.15 > 63.39
Short-term TENX quotes
Long-term TENX plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $0.00MM | $0.00MM | $0.00MM |
| Operating Expenses | $11.05MM | $8.23MM | $19.49MM |
| Operating Income | $-11.05MM | $-8.23MM | $-19.49MM |
| Non-Operating Income | $0.00MM | $0.52MM | $1.89MM |
| Interest Expense | $0.00MM | $0.02MM | $0.02MM |
| R&D Expense | $5.38MM | $3.23MM | $12.71MM |
| Income(Loss) | $-11.05MM | $-7.71MM | $-17.60MM |
| Profit(Loss)* | $-11.05MM | $-7.71MM | $-17.60MM |
| Stockholders Equity | $1.49MM | $8.10MM | $91.99MM |
| Assets | $3.40MM | $11.68MM | $96.69MM |
| Operating Cash Flow | $-11.39MM | $-5.90MM | $-14.81MM |
| Capital expenditure | $0.00MM | $0.00MM | $0.00MM |
| Investing Cash Flow | $-0.00MM | $0.00MM | $0.00MM |
| Financing Cash Flow | $7.93MM | $13.57MM | $99.87MM |
| Earnings Per Share** | $-600.72 | $-31.09 | $-1.15 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.